Cargando…
The effect of losartan therapy on ventricular function in Marfan patients with haploinsufficient or dominant negative FBN1 mutations
BACKGROUND: Mild biventricular dysfunction is often present in patients with Marfan syndrome. Losartan has been shown to reduce aortic dilatation in patients with Marfan syndrome. This study assesses the effect of losartan on ventricular volume and function in genetically classified subgroups of asy...
Autores principales: | den Hartog, A. W., Franken, R., van den Berg, M. P., Zwinderman, A. H., Timmermans, J., Scholte, A. J., de Waard, V., Spijkerboer, A. M., Pals, G., Mulder, B. J. M., Groenink, M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bohn Stafleu van Loghum
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5065542/ https://www.ncbi.nlm.nih.gov/pubmed/27704402 http://dx.doi.org/10.1007/s12471-016-0905-8 |
Ejemplares similares
-
The revised role of TGF-β in aortic aneurysms in Marfan syndrome
por: Franken, R., et al.
Publicado: (2014) -
Long-term clinical outcomes of losartan in patients with Marfan syndrome: follow-up of the multicentre randomized controlled COMPARE trial
por: van Andel, Mitzi M, et al.
Publicado: (2020) -
Resveratrol Inhibits Aortic Root Dilatation in the Fbn1(C1039G/+) Marfan Mouse Model
por: Hibender, Stijntje, et al.
Publicado: (2016) -
Genome-wide methylation patterns in Marfan syndrome
por: van Andel, Mitzi M., et al.
Publicado: (2021) -
Aortic distensibility in Marfan syndrome: a potential predictor of aortic events?
por: van Andel, Mitzi M, et al.
Publicado: (2021)